CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 254 filers reported holding CONMED CORP in Q3 2022. The put-call ratio across all filers is 1.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $27,857,450 | +30.8% | 205,000 | 0.0% | 0.66% | +30.5% |
| Q1 2023 | $21,291,300 | +17.2% | 205,000 | 0.0% | 0.51% | +16.2% |
| Q4 2022 | $18,171,200 | -2.7% | 205,000 | -12.0% | 0.44% | -9.3% |
| Q3 2022 | $18,680,000 | -12.5% | 233,000 | +4.5% | 0.48% | -22.4% |
| Q2 2022 | $21,354,000 | -29.0% | 223,000 | +10.1% | 0.62% | -18.0% |
| Q1 2022 | $30,081,000 | +4.8% | 202,500 | 0.0% | 0.76% | +14.2% |
| Q4 2021 | $28,706,000 | +35.0% | 202,500 | +24.6% | 0.66% | +48.3% |
| Q3 2021 | $21,260,000 | -4.8% | 162,500 | 0.0% | 0.45% | +1.4% |
| Q2 2021 | $22,332,000 | +101.0% | 162,500 | +91.0% | 0.44% | +82.2% |
| Q1 2021 | $11,111,000 | +27.2% | 85,085 | +9.1% | 0.24% | +30.8% |
| Q4 2020 | $8,736,000 | -38.3% | 78,000 | -56.7% | 0.18% | -48.5% |
| Q3 2020 | $14,161,000 | +9.3% | 180,000 | 0.0% | 0.36% | +1.1% |
| Q2 2020 | $12,958,000 | +25.7% | 180,000 | 0.0% | 0.36% | -16.7% |
| Q1 2020 | $10,309,000 | – | 180,000 | – | 0.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthCor Management, L.P. | 27,500 | $2,437,600 | 2.23% |
| Ranger Investment Management | 316,318 | $28,038,428 | 2.08% |
| Lighthouse Investment Partners, LLC | 142,100 | $12,595,744 | 1.39% |
| Lighthouse Investment Partners, LLC | 139,200 | $12,338,688 | 1.36% |
| EARNEST PARTNERS LLC | 2,402,352 | $212,944,481 | 1.30% |
| Lighthouse Investment Partners, LLC | 108,200 | $9,590,848 | 1.06% |
| MOODY ALDRICH PARTNERS LLC | 51,885 | $4,599,086 | 0.93% |
| MOUNTAIN PACIFIC INVESTMENT ADVISERS INC/ID | 125,435 | $11,118,558 | 0.81% |
| Champlain Investment Partners, LLC | 1,275,910 | $113,096,662 | 0.72% |
| EPIQ PARTNERS, LLC | 10,463 | $927,440 | 0.62% |